A randomized, double-blind study of the effect of Avastin [bevacizumab] plus gemcitabine and erlotinib compared with placebo plus gemcitabine and erlotinib on overall survival in patients with metastatic pancreatic cancer.
Phase of Trial: Phase III
Latest Information Update: 13 Oct 2014
At a glance
- Drugs Bevacizumab; Erlotinib; Gemcitabine
- Indications Pancreatic cancer
- Focus Adverse reactions; Registrational; Therapeutic Use
- Acronyms AVITA
- Sponsors Roche
- 13 Apr 2012 Trial status is recruiting in United kingdom as reported by European Clinical Trials Database record.
- 04 Oct 2010 New source identified and integrated (ClinicalTrials.gov: US National Institutes of Health).
- 04 Jun 2009 Results have been presented at the 45th Annual Meeting of the American Society of Clinical Oncology (ASCO).
Most Recent Events
Table of Contents
- At a glance
- Trial Overview
- Trial Details
- Trial Centres
- Trial History